These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development and applications of the SCID-hu mouse model. McCune JM Semin Immunol; 1996 Aug; 8(4):187-96. PubMed ID: 8883141 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Kaneshima H; Shih CC; Namikawa R; Rabin L; Outzen H; Machado SG; McCune JM Proc Natl Acad Sci U S A; 1991 May; 88(10):4523-7. PubMed ID: 1903543 [TBL] [Abstract][Full Text] [Related]
4. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Bonyhadi ML; Kaneshima H Mol Med Today; 1997 Jun; 3(6):246-53. PubMed ID: 9211415 [TBL] [Abstract][Full Text] [Related]
5. HIV-1-associated pathology in hemato-lymphoid organs and the experimental evaluation in the SCID-hu mouse. Kaneshima H Int J Hematol; 1996 Jun; 63(4):253-64. PubMed ID: 8762809 [TBL] [Abstract][Full Text] [Related]
6. Suppression of HIV infection in AZT-treated SCID-hu mice. McCune JM; Namikawa R; Shih CC; Rabin L; Kaneshima H Science; 1990 Feb; 247(4942):564-6. PubMed ID: 2300816 [TBL] [Abstract][Full Text] [Related]
7. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. McCune JM; Namikawa R; Kaneshima H; Shultz LD; Lieberman M; Weissman IL Science; 1988 Sep; 241(4873):1632-9. PubMed ID: 2971269 [TBL] [Abstract][Full Text] [Related]
8. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Rabin L; Hincenbergs M; Moreno MB; Warren S; Linquist V; Datema R; Charpiot B; Seifert J; Kaneshima H; McCune JM Antimicrob Agents Chemother; 1996 Mar; 40(3):755-62. PubMed ID: 8851606 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180 [TBL] [Abstract][Full Text] [Related]
10. Construction of human-SCID chimeric mice. Roncarolo MG; Carballido JM Curr Protoc Immunol; 2001 May; Chapter 4():4.8.1-4.8.17. PubMed ID: 18432798 [TBL] [Abstract][Full Text] [Related]
11. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. McCune J; Kaneshima H; Krowka J; Namikawa R; Outzen H; Peault B; Rabin L; Shih CC; Yee E; Lieberman M Annu Rev Immunol; 1991; 9():399-429. PubMed ID: 1910684 [TBL] [Abstract][Full Text] [Related]
12. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863 [TBL] [Abstract][Full Text] [Related]
13. Infection of the SCID-hu mouse by HIV-1. Namikawa R; Kaneshima H; Lieberman M; Weissman IL; McCune JM Science; 1988 Dec; 242(4886):1684-6. PubMed ID: 3201256 [TBL] [Abstract][Full Text] [Related]
14. Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo. Koka PS; Kitchen CM; Reddy ST J Virol; 2004 Oct; 78(20):11385-92. PubMed ID: 15452260 [TBL] [Abstract][Full Text] [Related]
15. Human T-and B-cell functions in SCID-hu mice. Roncarolo MG; Carballido JM; Rouleau M; Namikawa R; de Vries JE Semin Immunol; 1996 Aug; 8(4):207-13. PubMed ID: 8883143 [TBL] [Abstract][Full Text] [Related]
16. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891 [TBL] [Abstract][Full Text] [Related]
18. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. Pettoello-Mantovani M; Kollmann TR; Katopodis NF; Raker C; Kim A; Yurasov S; Wiltshire H; Goldstein H J Infect Dis; 1998 Feb; 177(2):337-46. PubMed ID: 9466519 [TBL] [Abstract][Full Text] [Related]
19. Long-term human hematopoiesis in the SCID-hu mouse. Namikawa R; Weilbaecher KN; Kaneshima H; Yee EJ; McCune JM J Exp Med; 1990 Oct; 172(4):1055-63. PubMed ID: 2212942 [TBL] [Abstract][Full Text] [Related]
20. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Kollmann TR; Kim A; Zhuang X; Hachamovitch M; Goldstein H Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8032-6. PubMed ID: 7914701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]